Podcast: 'Special K' as potential OCD treatment
In this podcast, Stanford psychiatrist Carolyn Rodriguez, MD, PhD, discusses how she got interested in the use of ketamine to treat obsessive-compulsive disorder and how she is determined to find out why, in studies, the drug has provided relief from symptoms.
Heart disease’s link to shingles explained
People with coronary artery disease face an elevated risk for shingles because aberrant immune cells dial down the body’s immune response to viral pathogens, Stanford research shows.
Molecule aids muscle regeneration in mice
Stanford researchers have found that a metabolite stimulates mouse muscle stem cells to proliferate after injury, and anti-inflammatory drugs, frequently taken after exercise, block its production and inhibit muscle repair.
Staff award winners announced
The winners of the 2017 Spirit Award are Christine Hendricks and Ana Mezynski. Kim Walker and Mary Ayers received the 2017 Inspiring Change Leadership Award.
Kenneth Vosti dies at 88
An authority on the causes and management of infectious diseases, Vosti was also known as a committed teacher and administrator, admired for his empathy and warmth.
Mouse lemur as model for human disease
Stanford researchers have identified more than 20 mouse lemurs with genetic traits for conditions such as heart disease and eye problems, making the tiny primates potentially useful for understanding diseases in humans.
Morioka-Douglas wins professionalism award
The Stanford clinical professor of medicine was honored for her efforts to help low-income communities.
Pilot grants for population health projects
The Stanford Center for Population Health Sciences has awarded 11 pilot grants to investigators with studies that seek to improve population and community health.
Deisseroth wins Fresenius Prize
The Stanford psychiatrist, neuroscientist and bioengineer will be honored for three distinct contributions to the medical field: optogenetics, hydrogel-tissue chemistry and research into depression.
Data sifting finds hidden gene partnerships
Targeting backup biological pathways often used by cancers can lead to more efficient drug development and less-toxic therapies. Stanford researchers have developed a new way to identify these pathways.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.